AMC
AMC Entertainment Holdings, Inc.
AMC lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
CHR
Cheer Holding, Inc.
There isn't enough reported data to score CHR yet.
AMC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Stable | |
| Under pressure |
AMC's revenue is currently healthy, and its profitability and cash flow are stable, but its balance sheet is under pressure.
CHR Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| Stable | |
| Healthy |
CHR's profitability and balance sheet are currently healthy, and its cash flow is stable, but its revenue is under pressure.
AMC PE Valuation
AMC has no meaningful PE right now: it lost money over the past year.
CHR PE Valuation
CHR has no meaningful PE right now: it lost money over the past year.
AMC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect AMC's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
CHR Forward outlook
There aren't enough analyst estimates for CHR to show an outlook.
AMC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.40 | +$0.94 |
| Q2 2026 | -$1.10 | -$0.28 |
| Q1 2026 | -$1.09 | -$0.18 |
| Q4 2025 | -$1.34 | -$0.28 |
| Q3 2025 | -$1.34 | +$0.29 |
| Q2 2025 | -$0.82 | +$0.67 |
| Q1 2025 | -$0.91 | +$0.38 |
| Q4 2024 | -$1.06 | +$1.31 |
AMC lost $0.40 per share over the past year, a smaller loss than the year before.
CHR Earnings Per Share
CHR and AMC do not have enough comparable growth data to identify a winner.
AMC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.7B | +32% |
| Q2 2026 | $1.6B | +14% |
| Q1 2026 | $1B | +21% |
| Q4 2025 | $1.3B | -1.4% |
| Q3 2025 | $1.3B | -3.6% |
| Q2 2025 | $1.4B | +36% |
| Q1 2025 | $862.5M | -9.3% |
| Q4 2024 | $1.3B | +18% |
AMC has the edge over CHR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +12 points |
| Q2 2026 | 15% | +8.3 points |
| Q1 2026 | -4.4% | +13 points |
| Q4 2025 | 0% | -0.3 points |
| Q3 2025 | 2.8% | -2.6 points |
| Q2 2025 | 6.6% | +11 points |
| Q1 2025 | -17% | -5.5 points |
| Q4 2024 | 0.4% | +14 points |
AMC's operating margin was 15% last quarter, up 12 points from the same quarter a year ago, near the top of its range since 2019.
CHR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $30.3M | -15% |
| Q1 2026 | $30.3M | -15% |
| Q4 2025 | $38.9M | +2.2% |
| Q3 2025 | $38.9M | +2.2% |
| Q2 2025 | $35.5M | -50% |
| Q4 2024 | $38.1M | -55% |
| Q2 2024 | $71.1M | +5.4% |
| Q4 2023 | $84.9M | -2.6% |
CHR's revenue has slid since its 2022 peak: $30M last quarter, down 15% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 17% | +5.6 points |
| Q1 2026 | 17% | +5.6 points |
| Q4 2025 | 23% | +4.8 points |
| Q3 2025 | 23% | +4.8 points |
| Q2 2025 | 12% | -4.6 points |
| Q1 2025 | 12% | N/A |
| Q4 2024 | 18% | -5.9 points |
| Q3 2024 | 18% | N/A |
CHR has the edge over AMC on profitability, with a higher operating margin.
AMC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $109.3M | +$190.4M |
| Q2 2026 | $190.1M | +114% |
| Q1 2026 | -$174.7M | +$242.3M |
| Q4 2025 | $43.3M | -62% |
| Q3 2025 | -$81.1M | +$11.1M |
| Q2 2025 | $88.9M | +$168.1M |
| Q1 2025 | -$417M | -$178.2M |
| Q4 2024 | $113.9M | +$263.8M |
AMC has the edge over CHR on cash flow, with more consistent year-over-year improvement.
CHR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$15.1M | -871% |
| Q1 2026 | $17.9M | +815% |
| Q4 2025 | $7M | -53% |
| Q3 2025 | $7M | -53% |
| Q2 2025 | $2M | +$8.7M |
| Q1 2025 | $2M | +$5.3M |
| Q4 2024 | $14.8M | -1.3% |
| Q3 2024 | $14.8M | +97% |
CHR usually generates cash, though not every quarter: the latest was −$15M, but it generated $17M over the past year.
AMC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +24% | +175M shares |
| 1 year | +107% | +463M shares |
| 3 years | +767% | +793M shares |
| 5 years | +4063% | +875M shares |
AMC has 897M diluted shares, up 107% from a year ago.
CHR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | -62% | -124K shares |
| 3 years | +1564% | +72.6K shares |
CHR has the edge over AMC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
AMC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 9.2x | High |
| Q4 2025 | 12.2x | High |
| Q3 2025 | 12.2x | High |
| Q2 2025 | 10.7x | High |
| Q1 2025 | 18.6x | High |
| Q4 2024 | 14.3x | High |
AMC's net debt is about 4.0 years of its operating earnings (EBITDA), down from 12 years a year ago.
CHR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -4.8x | Net Cash |
| Q1 2026 | -5.0x | Net Cash |
| Q4 2025 | -6.7x | Net Cash |
| Q3 2025 | -7.6x | Net Cash |
| Q2 2025 | -7.5x | Net Cash |
| Q1 2025 | -5.7x | Net Cash |
CHR has the edge over AMC on leverage, with a lower net debt burden relative to earnings.
AMC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 67.3 | Neutral |
| Stochastic | 65.4 | Neutral |
AMC's weekly RSI is 67 (neutral) and its Stochastic is 65 (neutral).
CHR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 25.6 | Oversold |
| Stochastic | 15.4 | Oversold |
CHR's weekly RSI is 26 (oversold) and its Stochastic is 15 (oversold).
AMC PE vs Communication Services Sector
AMC has no meaningful PE right now: it lost money over the past year.
CHR PE vs Communication Services Sector
CHR has no meaningful PE right now: it lost money over the past year.
AMC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.01 | 11% above |
| 20 week MA | $2.64 | 27% above |
| 50 week MA | $2.01 | 66% above |
| 100 week MA | $2.53 | 32% above |
| 200 week MA | $10.9 | 69% below |
AMC has the edge over CHR on trend strength, trading above more of its moving averages.
CHR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.43 | 7.7% below |
| 20 week MA | $1.67 | 21% below |
| 50 week MA | $2.59 | 49% below |
| 100 week MA | $103.9 | 99% below |
| 200 week MA | $363.1 | 100% below |
CHR is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
AMC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $36.5 | $12.6 | -66% |
| 2021 | $12.6 | $142.6 | +1036% |
| 2022 | $142.6 | $44.0 | -69% |
| 2023 | $44.0 | $6.12 | -86% |
| 2024 | $6.12 | $4.00 | -35% |
| 2025 | $4.00 | $1.69 | -58% |
| 2026 YTD | $1.69 | $3.34 | +98% |
AMC has the edge over CHR on returns for 2026, with the stronger performance.
CHR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15,450.0 | $3,945.0 | -74% |
| 2021 | $3,945.0 | $1,935.0 | -51% |
| 2022 | $1,935.0 | $2,220.0 | +15% |
| 2023 | $2,220.0 | $471.0 | -79% |
| 2024 | $471.0 | $387.0 | -18% |
| 2025 | $387.0 | $4.38 | -99% |
| 2026 YTD | $4.38 | $1.32 | -70% |
CHR has finished three years in a row lower, and it's down 70% so far in 2026.